Designer lipids advance systemic siRNA delivery.
暂无分享，去创建一个
[1] R. Hickerson,et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[2] K. G. Rajeev,et al. Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.
[3] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[4] John J. Rossi,et al. The promises and pitfalls of RNA-interference-based therapeutics , 2009, Nature.
[5] J. Ruysschaert,et al. Cationic liposomal lipids: from gene carriers to cell signaling. , 2008, Progress in lipid research.
[6] Keith Bowman,et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.
[7] P. Cullis,et al. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.
[8] F. Szoka,et al. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. , 1996, Biochemistry.
[9] J. Northrop,et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.